These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 29680812)
1. A smartphone application for reporting symptoms in adults with cystic fibrosis: protocol of a randomised controlled trial. Wood J; Jenkins S; Putrino D; Mulrennan S; Morey S; Cecins N; Hill K BMJ Open; 2018 Apr; 8(4):e021136. PubMed ID: 29680812 [TBL] [Abstract][Full Text] [Related]
2. A smartphone application for reporting symptoms in adults with cystic fibrosis improves the detection of exacerbations: Results of a randomised controlled trial. Wood J; Jenkins S; Putrino D; Mulrennan S; Morey S; Cecins N; Bear N; Hill K J Cyst Fibros; 2020 Mar; 19(2):271-276. PubMed ID: 31522924 [TBL] [Abstract][Full Text] [Related]
3. Digital technology for early identification of exacerbations in people with cystic fibrosis. Wong CH; Smith S; Kansra S Cochrane Database Syst Rev; 2023 Apr; 4(4):CD014606. PubMed ID: 37057835 [TBL] [Abstract][Full Text] [Related]
4. A prospective pilot study of home monitoring in adults with cystic fibrosis (HOME-CF): protocol for a randomised controlled trial. Choyce J; Shaw KL; Sitch AJ; Mistry H; Whitehouse JL; Nash EF BMC Pulm Med; 2017 Jan; 17(1):22. PubMed ID: 28114922 [TBL] [Abstract][Full Text] [Related]
5. High usability of a smartphone application for reporting symptoms in adults with cystic fibrosis. Wood J; Jenkins S; Putrino D; Mulrennan S; Morey S; Cecins N; Hill K J Telemed Telecare; 2018 Sep; 24(8):547-552. PubMed ID: 28799841 [TBL] [Abstract][Full Text] [Related]
6. Macrolide antibiotics (including azithromycin) for cystic fibrosis. Southern KW; Solis-Moya A; Kurz D; Smith S Cochrane Database Syst Rev; 2024 Feb; 2(2):CD002203. PubMed ID: 38411248 [TBL] [Abstract][Full Text] [Related]
7. A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis. Nash EF; Choyce J; Carrolan V; Justice E; Shaw KL; Sitch A; Mistry H; Whitehouse JL Ther Adv Respir Dis; 2022; 16():17534666211070133. PubMed ID: 35274585 [TBL] [Abstract][Full Text] [Related]
8. CyFiT telehealth: protocol for a randomised controlled trial of an online outpatient physiotherapy service for children with cystic fibrosis. Lang RL; Wilson C; Stockton K; Russell T; Johnston LM BMC Pulm Med; 2019 Jan; 19(1):21. PubMed ID: 30678670 [TBL] [Abstract][Full Text] [Related]
9. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796 [TBL] [Abstract][Full Text] [Related]
10. Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis. Dawson S; Girling CJ; Cowap L; Clark-Carter D Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013766. PubMed ID: 36989170 [TBL] [Abstract][Full Text] [Related]
11. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial. Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998 [TBL] [Abstract][Full Text] [Related]
12. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT. Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975 [TBL] [Abstract][Full Text] [Related]
13. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. Smith S; Rowbotham NJ; Charbek E Cochrane Database Syst Rev; 2022 Aug; 8(8):CD008319. PubMed ID: 35914011 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of an innovative mobile health programme for the self-management of chronic obstructive pulmonary disease (MH-COPD): protocol of a randomised controlled trial. Ding H; Karunanithi M; Ireland D; McCarthy L; Hakim R; Phillips K; Pradhan R; Seah EH; Bowman RV; Fong K; Masel P; Yang IA BMJ Open; 2019 Apr; 9(4):e025381. PubMed ID: 31028038 [TBL] [Abstract][Full Text] [Related]
15. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. Smith S; Rowbotham NJ; Charbek E Cochrane Database Syst Rev; 2018 Oct; 10(10):CD008319. PubMed ID: 30376155 [TBL] [Abstract][Full Text] [Related]
16. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)]. ; ; Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700 [TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
18. A web-based intervention to promote physical activity in adolescents and young adults with cystic fibrosis: protocol for a randomized controlled trial. Cox NS; Eldridge B; Rawlings S; Dreger J; Corda J; Hauser J; Button BM; Bishop J; Nichols A; Middleton A; Ward N; Dwyer T; Tomlinson OW; Denford S; Barker AR; Williams CA; Kingsley M; O'Halloran P; Holland AE; BMC Pulm Med; 2019 Dec; 19(1):253. PubMed ID: 31856791 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of negative pressure wound therapy in the prevention of surgical wound complications in the cesarean section at-risk population: a parallel group randomised multicentre trial-the CYGNUS protocol. Sandy-Hodgetts K; Parsons R; Norman R; Fear MW; Wood FM; White SW BMJ Open; 2020 Oct; 10(10):e035727. PubMed ID: 33077559 [TBL] [Abstract][Full Text] [Related]